top of page
dniven_a_professional_minimalist_photo_realistic_image_of_a_sty_773c2d35-49b4-4205-adfd-38

Market access and growth strategy:
from insight to implementation

Niven Biopharma supports life sciences and healthcare companies in turning complex market access and growth challenges into clear strategies, practical plans and scalable commercial capabilities.

When to work with Niven Biopharma

When you need senior, objective support to work through a complex strategic problem, prepare for a significant investment or business decision, or bring a clearer external market perspective to internal planning.

dniven_a_professional_minimalist_photo_realistic_image_of_a_s_c610be29-5a97-467f-a3e2-b5d8

Services

Market Access

Market Access Strategy 

Helping organisations understand value, evidence, payer needs, and routes to access.

Growth Strategy

Helping organisations identify opportunities, understand customers and translate growth priorities into practical plans.

Commercial Capability

Helping teams turn strategy into effective operating models, resources, processes and scalable capabilities.

Why Niven Biopharma?

✔ Senior life sciences and healthcare experience

​

✔ Clear thinking from strategy through to implementation

​

✔ AI-enabled tools and ways of working that increase the speed, depth and efficiency of delivery

​

✔ Experienced judgement at the heart of every engagement

dniven_a_professional_minimalist_photo_realistic_image_of_a_sty_7f01bead-a759-4865-bc13-d0

Example projects

Recent work has helped life sciences and healthcare organisations translate market access and growth priorities into strategic decisions, practical plans and new commercial capabilities.

​

Global market access landscape and indication strategy
Developed a global market access landscape across 10+ countries for a biotech evaluating two potential therapeutic indications. The work combined secondary research, stakeholder interviews and quantitative research to assess access opportunity, pricing corridor, payer expectations and market viability. Findings were used to inform pivotal trial design and portfolio strategy.

​

European cancer services growth strategy
Supported a European healthcare services company in developing its cancer strategy across public and private markets. Work included business strategy, end-to-end pathway design, customer engagement planning, and evidence generation. Outputs informed short- and long-term growth plans now being implemented across the business.​

​

Implementing a new sales model

Supported the implementation of a new sales model for a nationwide healthcare professional-facing team.

Developed the sales playbook alongside a technology-enabled training solution and helped facilitate a face-to-face training programme.

Combined practical tools, training and implementation support to help translate the new commercial model into consistent ways of working across the team.

Example Insights

Niven Biopharma Exec Brief Jul 26 Cover.jpg

Executive Brief

 

How should companies interpret the findings from the first JCA reports?

dniven_abstract_depiction_of_ideas_of_economic_pressures_coming_1f3e012a-4a66-4930-ab2a-3f

MFN Pricing and the “Global Launch Freeze”

 

A more measured perspective

Get in Touch

Contact Doug Niven

+34 685 92 39 41

    Let’s discuss how I can support your next market access, growth or commercial challenge.

    Thanks for submitting!

    bottom of page